Rifaximin reduces the incidence of spontaneous bacterial peritonitis, variceal bleeding and all-cause admissions in patients on the liver transplant waiting list.

Shayon SalehiThomas H TranahSamuel LimNigel HeatonMichael HeneghanVaruna AluvihareVishal C PatelDebbie Lindsay Shawcross

Published in: Alimentary pharmacology & therapeutics (2019)

Rifaximin prescribed for HE in patients listed for liver transplantation improved outcomes with significant reduction in admissions related to spontaneous bacterial peritonitis, ascites and variceal bleeding.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
type diabetes
risk factors
insulin resistance
cell free
drug induced